These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 16732389

  • 1. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR.
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract] [Full Text] [Related]

  • 2. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP.
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [Abstract] [Full Text] [Related]

  • 3. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H, Lask S, Engelhardt A, Mügge A.
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P, Jezovnik MK.
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [Abstract] [Full Text] [Related]

  • 6. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.
    Am J Cardiol; 2008 Aug 15; 102(4):396-400. PubMed ID: 18678294
    [Abstract] [Full Text] [Related]

  • 7. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H, Linnemann B, Luxembourg B, Kirchmayr K, Lindhoff-Last E.
    Platelets; 2006 Aug 15; 17(5):303-10. PubMed ID: 16928602
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
    Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A.
    Thromb Haemost; 2007 Jul 15; 98(1):201-9. PubMed ID: 17598014
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H, Lee HK, Han K, Jeon HK.
    Ann Clin Lab Sci; 2009 Jul 15; 39(3):289-94. PubMed ID: 19667414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K, Hughes JD, Lee YP, Parsons R.
    Qual Prim Care; 2011 Jul 15; 19(1):35-42. PubMed ID: 21703110
    [Abstract] [Full Text] [Related]

  • 17. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Wang TH, Bhatt DL, Topol EJ.
    Eur Heart J; 2006 Mar 15; 27(6):647-54. PubMed ID: 16364973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.